ACUTE REPETITIVE SEIZURES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Side effects associated with the treatments available for acute repetitive seizures can hamper the growth of the acute repetitive seizures market. The medications used for controlling acute repetitive seizures such as benzodiazepines, antiepileptic drugs, and others often cause serious adverse effects that significantly impact the patient's quality of life. Some common side effects include tiredness, dizziness, blurred vision, nausea, vomiting, behavioral changes, and others.  In some severe cases, the side effects of these drugs can even lead to life-threatening issues like bronchospasm, Stevens-Johnson syndrome and serious allergic reactions.

Market Opportunity – Expanding Applications in Developing Countries

Expanding applications in developing countries in acute repetitive seizures market represents a significant opportunity for the market growth in the near future. Developing nations across Asia, Latin America, Africa and parts of Eastern Europe are experiencing rapidly increasing incidences of epilepsy and recurrent seizures. According to the World Health Organization, epilepsy prevalence is expected to rise by over 18% in India and parts of sub-Saharan Africa between 2020-2030 as populations’ age and risk factors associated with trauma and infectious diseases remain high in these regions.